XML 84 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Geographic and Product Data
 12 Months Ended
Jan. 03, 2014
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]
Note 16 — Geographic and Product Data
 
The Company markets and sells its products in approximately 60 countries and has manufacturing sites in the United States and Switzerland. Other than the United States, Japan, Korea, China, and Spain, the Company does not conduct business in any country in which its sales in that country exceed 5% of consolidated sales. Sales are attributed to countries based on location of customers. The composition of the Company’s sales to unaffiliated customers is set forth below (in thousands):
 
Net sales to unaffiliated customers
 
2013
 
2012
 
2011
 
United States
 
$
12,851
 
$
12,427
 
$
13,852
 
Japan
 
 
17,666
 
 
16,692
 
 
15,690
 
Korea
 
 
7,743
 
 
6,713
 
 
8,142
 
China
 
 
8,618
 
 
8,406
 
 
6,354
 
Spain
 
 
4,867
 
 
—
 
 
—
 
Others*
 
 
20,470
 
 
19,545
 
 
18,727
 
Total
 
$
72,215
 
$
63,783
 
$
62,765
 
 
*No other location individually exceeds 5% of total sales.
   
100% of the Company’s sales are generated from the ophthalmic surgical product segment and, therefore, the Company operates as one operating segment for financial reporting purposes. The Company’s principal products are IOLs used in cataract surgery and ICLs used in refractive surgery.   The composition of the Company’s net sales by product line is as follows (in thousands):
 
Net sales by product line
 
2013
 
2012
 
 
2011
 
ICLs
 
$
44,128
 
$
35,080
 
$
32,072
 
IOLs
 
 
24,153
 
 
25,971
 
 
27,547
 
Other surgical products
 
 
3,934
 
 
2,732
 
 
3,146
 
Total
 
$
72,215
 
$
63,783
 
$
62,765
 
 
The composition of the Company’s long-lived assets, consisting of property and equipment, between those in the United States, Switzerland, and Japan is set forth below (in thousands):
 
Long-lived assets
 
2013
 
2012
 
U.S.
 
$
6,096
 
$
3,052
 
Switzerland
 
 
849
 
 
984
 
Japan
 
 
460
 
 
1,403
 
Total
 
$
7,405
 
$
5,439
 
 
The Company sells its products internationally, which subjects the Company to several potential risks, including fluctuating exchange rates (to the extent the Company’s transactions are not in U.S. dollars), regulation of fund transfers by foreign governments, United States and foreign export and import duties and tariffs, and political instability.